SINGLE- BLIND PLACEBO CONTROLLED CLINICAL EVALUATION OF MAMAJJAKA GHANVATI IN PRAMEHA W.S.R. DIABETES MELLITUS
DOI:
https://doi.org/10.70066/jahm.v1i5.112Keywords:
prameha, mamajjaka, ghanavati, Enicostemma Littorale Bloume, virechanaAbstract
Background:
Prameha (~Diabetes Mellitus) is described as one of the disease mainly caused by vitiation of tridosha. Prameha is one of the eight diseases which are tough to cure known as mahagada (merely curable disease) are numerated by Sushruta. The syndrome diabetes mellitus has been largely covered under the broad heading of prameha. According to the International Diabetes Federation (IDF), 3.8 million people worldwide die from diabetes and related illnesses annually. In only 20 years the number of people with diabetes has exploded from 30 million to 246 million. By 2025 there will be approximately 380 million people living with diabetes, with the highest increases in new cases occurring in the most diabetics at 40.9 million followed by China with 39.8 millions.
Objective:
To find out an effective and cheap remedy to combat against prameha (~Diabetes Mellitus).
Methods and Materials:
The study was carried out in the 60 patients of prameha selected from the O.P.D/I.P.D of govt. Ayurvedic College hospital Raipur; total of 52 patients completed the full course of treatment. Out of this figure, 20 patients were studied in shamana Group who were given mamajjaka ghanavati, second group with virechana karma fallowed by mamajjaka ghanavati and rest 20 patients Were studied in control group who were given godanti bhasma as placebo treatment.
Results:
The trial drug & virechana (bio-purification) therapy shows highly significant result on objective parameter like reduction in Fasting Blood Sugar level, reduction in Post Prandial Blood Sugar level, along with clinical improvements on subjective parameters like excessive urination, turbidity of urine, excessive thirst, burning sensation in hand and leg, excessive sweating, ,excessive hunger & tiredness etc.
Conclusion:
The drug under trial, mamajjaka ghanavati was effective in Diabetes Mellitus conditions.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 AMARNATH SHUKLA
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The author(s) will retain copyright and permit the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that permits others to share the work with an acknowledgment of the author and initial publication in this journal.
The entire contents of the JAHM are protected under Indian and international copyrights. The Journal, however, allows free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, perform and display the work publicly and to make and distribute works in any online website for any non-commercial purpose, subject to proper attribution of authorship and ownership of the rights. The journal also permits the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Noncommercial-Share Alike 4.0 License.
In case of JAHM does not publish said work, the author(s) will be so notified and all rights assigned hereunder will be given back to the author(s).
All accepted works should not be published anywhere without prior written permission from JAHM. The author(s) hereby declare that they are sole author(s) of the work, that all authors have contributed and agree with the content and conclusions of the work, that the work is original, and does not infringe upon any copyright, propriety, or personal right of any third party, and that no part of it nor any work has been submitted to another journal.
